Bailey’s Wellness, LLC dba Bailey’s CBD
Received an FDA warning letter over CBD products, including some marketed for animals
Not yet reviewed by our editors. This entry reports what the cited sources say; it may change as we check it. How we check
This entry is about the United States — not the country you picked in the header.
According to U.S. Food and Drug Administration, Apr 7, 2025 · Read the source · +1 more
Summary
Bailey’s Wellness, LLC dba Bailey’s CBD received an FDA warning letter dated April 7, 2025, issued by the Center for Veterinary Medicine (CVM). According to the letter, the FDA reviewed the company's web presence (baileyscbd.com) and found products represented as containing CBD. Product types mentioned include topicals (creams, balms, salves), pet or animal treats, oils and concentrates, powders and pellets. Products named in the letter include “CBD Pellets for Horses”; “CBD Paw & Nose Balm”.
The FDA states that the products are unapproved new animal drugs and adulterated under the Federal Food, Drug, and Cosmetic Act, and that those sold as foods contain an unsafe food additive. The quoted marketing claims concern cancer, arthritis, seizures, anxiety. The letter asks the company to reply within fifteen working days describing the steps it has taken.
What the source found
- Letter date April 7, 2025; FDA reference (MARCS-CMS) 701066; issued by the Center for Veterinary Medicine (CVM).
- Website(s) named in the letter: baileyscbd.com.
- Alleged violations cited by the FDA: unapproved new animal drugs, adulterated products (FD&C Act).
- Claims quoted by the FDA relate to: cancer, arthritis, seizures, anxiety, insomnia.
- Named products: CBD Pellets for Horses; CBD Paw & Nose Balm.
- No close-out letter was listed on the FDA warning letters page at retrieval (30 Sep 2026).
Products named
- CBD products
- topicals (creams, balms, salves)
- pet or animal treats
- oils and concentrates
Timeline
FDA warning letter issued
Letter posted on FDA.gov
Sources
- Regulator
U.S. Food and Drug Administration · Apr 7, 2025
Warning letter: Bailey’s Wellness, LLC dba Bailey’s CBD (701066), April 7, 2025 - Regulator
U.S. Food and Drug Administration
Warning Letters and Test Results for Cannabidiol-Related Products
Wording on this page follows the sources. Found an error? See the corrections process in our editorial policy.
Status notes
[dataset] FDA warning letters database (fda.gov), harvested 2026-09-30; letter text read by script, cited as written by the source.
Comments
No comments yet.
Related entries
The full Red ListTell us what happened
Every report is read by a person. You don’t need to prove anything, and we never publish your name.
- A moderator reads your report and checks the link against the Red List and our seller records.
- We look for an authoritative source — a regulator, court, police or consumer-protection finding.
- When a source confirms it, your report is linked to a Red List entry. Your name and contact details stay private.